nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—REN—adrenal gland cancer	0.137	0.183	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0794	0.106	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0466	0.062	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—GNRH1—adrenal gland cancer	0.0376	0.05	CbGpPWpGaD
Fludrocortisone—NR3C1—urine—adrenal gland cancer	0.0373	0.189	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0368	0.049	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0354	0.047	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.028	0.0372	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—adrenal gland cancer	0.0219	0.0291	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—DAXX—adrenal gland cancer	0.0205	0.0272	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—CDC42—adrenal gland cancer	0.0204	0.0271	CbGpPWpGaD
Fludrocortisone—NR3C2—adrenal cortex—adrenal gland cancer	0.0184	0.0932	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.0154	0.0205	CbGpPWpGaD
Fludrocortisone—NR3C2—cardiac atrium—adrenal gland cancer	0.0152	0.0771	CbGeAlD
Fludrocortisone—NR3C2—pituitary gland—adrenal gland cancer	0.0149	0.0753	CbGeAlD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—adrenal gland cancer	0.0146	0.0193	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.0137	0.0182	CbGpPWpGaD
Fludrocortisone—AR—adrenal cortex—adrenal gland cancer	0.0136	0.069	CbGeAlD
Fludrocortisone—NR3C2—adrenal gland—adrenal gland cancer	0.0133	0.0673	CbGeAlD
Fludrocortisone—AR—gonad—adrenal gland cancer	0.0113	0.0572	CbGeAlD
Fludrocortisone—AR—cardiac atrium—adrenal gland cancer	0.0113	0.0571	CbGeAlD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.0111	0.0148	CbGpPWpGaD
Fludrocortisone—AR—pituitary gland—adrenal gland cancer	0.011	0.0558	CbGeAlD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.0103	0.0137	CbGpPWpGaD
Fludrocortisone—NR3C1—adrenal cortex—adrenal gland cancer	0.00988	0.05	CbGeAlD
Fludrocortisone—AR—adrenal gland—adrenal gland cancer	0.00985	0.0498	CbGeAlD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RB1—adrenal gland cancer	0.00913	0.0121	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.00878	0.0117	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.00838	0.0111	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00824	0.011	CbGpPWpGaD
Fludrocortisone—NR3C1—gonad—adrenal gland cancer	0.00818	0.0414	CbGeAlD
Fludrocortisone—NR3C1—cardiac atrium—adrenal gland cancer	0.00817	0.0414	CbGeAlD
Fludrocortisone—NR3C1—pituitary gland—adrenal gland cancer	0.00798	0.0404	CbGeAlD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00788	0.0105	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.00767	0.0102	CbGpPWpGaD
Fludrocortisone—NR3C1—adrenal gland—adrenal gland cancer	0.00713	0.0361	CbGeAlD
Fludrocortisone—Megestrol acetate—ABCB1—adrenal gland cancer	0.00704	0.14	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0066	0.00878	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR5A1—adrenal gland cancer	0.0066	0.00878	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—adrenal gland cancer	0.00652	0.00867	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00638	0.00848	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00636	0.00846	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00575	0.00765	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.00548	0.00729	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—adrenal gland cancer	0.00545	0.00725	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—adrenal gland cancer	0.00539	0.107	CrCbGaD
Fludrocortisone—Triamcinolone—PTGS2—adrenal gland cancer	0.00535	0.106	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.00525	0.00698	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00501	0.00666	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00483	0.00642	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.00457	0.00608	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00447	0.00594	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.00443	0.00589	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.00439	0.00584	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—adrenal gland cancer	0.00438	0.0869	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—adrenal gland cancer	0.00438	0.0868	CrCbGaD
Fludrocortisone—Prednisone—ABCB1—adrenal gland cancer	0.00412	0.0818	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.00403	0.00536	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00401	0.00534	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MED12—adrenal gland cancer	0.00397	0.00528	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00382	0.00509	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—adrenal gland cancer	0.0038	0.0754	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—MEN1—adrenal gland cancer	0.00379	0.00504	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—adrenal gland cancer	0.00379	0.00504	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—adrenal gland cancer	0.00372	0.0739	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.0037	0.00493	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00366	0.00486	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00365	0.00486	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00359	0.00477	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00333	0.00442	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.00319	0.00425	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—RB1—adrenal gland cancer	0.00307	0.00408	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR5A1—adrenal gland cancer	0.00306	0.00407	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—adrenal gland cancer	0.00291	0.0577	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.0029	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00277	0.00369	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00264	0.00351	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00257	0.00342	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—adrenal gland cancer	0.00255	0.0505	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00246	0.00328	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00244	0.00325	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—adrenal gland cancer	0.00237	0.047	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NR5A1—adrenal gland cancer	0.00232	0.00309	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—adrenal gland cancer	0.00226	0.003	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—adrenal gland cancer	0.00224	0.0444	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00219	0.00291	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00217	0.00289	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—adrenal gland cancer	0.00217	0.043	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.00209	0.00278	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00195	0.00259	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MED12—adrenal gland cancer	0.00184	0.00245	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MEN1—adrenal gland cancer	0.00176	0.00234	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.00176	0.00234	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00173	0.0023	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00146	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MED12—adrenal gland cancer	0.0014	0.00186	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MEN1—adrenal gland cancer	0.00134	0.00178	CbGpPWpGaD
